InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,458.27
(
0.49%
)
US TECH 100
19,292.80
(
0.65%
)
Dow Jones
38,681.33
(
0.24%
)
Brent Oil
83.33
(
1.46%
)
Bitcoin
65,922.17
(
-1.08%
)
Post# of 182952
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

stock1ace1

Send PM Follow Ignore
Followers 276
Posts 36520
Boards Moderated 2
Alias Born 04/05/2012

stock1ace1

Re: Lone Wolf post# 82550

Thursday, 07/20/2017 7:45:48 AM

Thursday, July 20, 2017 7:45:48 AM

Post# of 182952
6-26-17 PR, KTOV expects that the formal filing of the NDA by the FDA will occur by the end of the 3rd quarter of 2017.
Next paragraph:
Given the excellent results of our phase3 clinical trial were confident that KIT-302 will be approved by the FDA and become a successful treatment for osteoorthritis and hypertension.


D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up